Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate.

Authors
Category Primary study
JournalSN comprehensive clinical medicine
Year 2020
Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug-drug interactions (DDIs).
Epistemonikos ID: 480c4d1c3c4e4302e8b00dae3b692d76ab7fbab0
First added on: Dec 04, 2020